Open Access

UVB radiation represses CYLD expression in melanocytes

  • Authors:
    • Silke Kuphal
    • Nadja Schneider
    • Ramin Massoumi
    • Claus Hellerbrand
    • Anja Katrin Bosserhoff
  • View Affiliations

  • Published online on: October 3, 2017
  • Pages: 7262-7268
  • Copyright: © Kuphal et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


CYLD lysine 63 deubiquitinase (CYLD) was originally identified as a tumor suppressor that is mutated in familial cylindromatosis. Unlike in cylindromatosis, downregulation of the deubiquitinase CYLD in melanoma, a highly aggressive tumor, is not caused by mutations in the CYLD gene, but rather by a constitutive and high expression of the snail family transcriptional repressor 1 (SNAIL1). A reduced CYLD level leads to B‑cell lymphoma‑3/p50/p52‑dependent nuclear factor‑κB activation, which in turn triggers the expression of genes such as cyclin D1 and N‑cadherin. Elevated levels of cyclin D1 and N‑cadherin promote melanoma proliferation and invasion. By analyzing the regulation of CYLD expression in melanocytes, the present study identified a signaling pathway that is regulated in response to ultraviolet B (UVB) radiation in melanocytes. UVB light leads to an extracellular signal‑regulated kinase‑mediated induction of SNAIL1 and subsequent downregulation of CYLD expression in normal human epithelial melanocytes. The UVB‑mediated suppression of CYLD in melanocytes may have a key role in the reaction to UV stimuli, and may also potentially be involved in the early malignant transformation processes.


Cutaneous melanoma is a heterogeneous disease affecting the regulation of multiple genes and proteins that contribute to the strong proliferation and invasion of degenerated melanocytes into the dermis and subsequent metastatic dissemination of melanoma cells and progression of the disease (1).

Ultraviolet (UV) light exposure is considered an important predisposing factor that triggers continuous proliferation of certain melanocytes, which do not undergo senescence, and therefore support the development of melanoma (2). In melanocytes, UV light usually induces pigmentation. In this case, proliferation and pigment production is stimulated by UV-induced DNA damage to keratinocytes, which subsequently secrete α-melanocyte stimulating hormone (αMSH) (3). αMSH binds to the melanocortin 1 receptor, which is expressed on melanocytes (4). Additional research demonstrated that UVB-induced DNA lesions also cause genetic mutations directly in melanocytes, with C→T transitions at dipyrimidine sites (5).

However, recent findings revealed that the photo-carcinogenesis pathway is more complex, with consequences in which each of these processes, mediated by various cellular, biochemical and molecular changes, are closely associated with each other (6).

Although UVA is the most prevalent component of solar UV radiation reaching the surface of the Earth, it mainly causes skin photo-aging (solar elastosis), but it is less carcinogenic compared to UVB radiation (7). By contrast, although UVB radiation only constitutes a minor part of solar radiation, it is carcinogenic at significantly lower doses compared with UVA radiation. UVB has a direct mutagenic effect on DNA as it is maximally absorbed by this primary chromophore (8). UV photon energy absorption by DNA decreases constantly at longer wavelengths (in the UVA range); therefore, UVB radiation is considered the major cause of skin cancer (9,10). Notably, Noonan et al (11) reported that only a single dose of burning UV radiation to neonate hepatocyte growth factor/scatter factor-transgenic mice is necessary and sufficient to induce melanoma with a high incidence. Although supported by several studies, the molecular mechanism of melanoma induction by UV irradiation is not fully understood (12,13).

Cyld was first identified as a gene associated with familial cylindromatosis, a disease showing multiple benign skin tumors that result from Cyld germline mutations (usually nonsense or missense mutations) associated with somatic mutations in dermal cells (loss of heterozygosity) (14). In previous studies, the expression and function of CYLD in malignant melanoma and basal cell carcinoma has been analyzed (15,16). These uncovered a new mechanism, revealing that the zinc-finger transcription factor SNAIL1 drives melanoma cells to a mitogenic and metastatic phenotype via downregulating the expression of CYLD. Loss of CYLD paves the way for activation of p50/p52 subunits of nuclear factor-κB (NF-κB), resulting in stimulation of the expression of genes, including cyclin D1 and N-cadherin expression. The induced target genes consequently lead to enhanced proliferation, migration and invasiveness of melanoma cells in vitro, as well as tumor growth and metastasis in vivo. Notably, increased SNAIL1 expression and reduced CYLD levels are inversely correlated with progression-free and overall survival of melanoma patients (16). Thus, it was shown that SNAIL1 has an important role in melanoma progression (17) and that one of the molecular mechanisms involved is the downregulation of CYLD. However, the role of SNAIL1 and CYLD in melanocyte proliferation and migration, as well as early malignant transformation, remains elusive.

In the present study, the effect of UVB radiation, one of the major promoting factors for the development of skin cancer, on SNAIL1 expression was investigated. Induced signaling via the ERK-SNAIL1 axis in normal primary human melanocytes, which reduces CYLD expression in UVB dependency, was identified.

Materials and methods

Cells and cell culture

The melanoma cell line Mel Ei was derived from a primary cutaneous melanoma, and the melanoma cell line Mel Im was isolated from metastasis. These cell lines were provided by Professor Judith P. Johnson (Cancer Immunology, Ludwig-Maximilians University, Munich, Germany) (18). The cell lines were cultured in Dulbecco's modified Eagle's medium, supplemented with penicillin (400 U/ml), streptomycin (50 µg/ml) and 10% fetal calf serum (all Sigma-Aldrich; Merck KGaA, Darmstadt, Germany). Primary normal human epidermal melanocytes (NHEMs) were isolated and cultured as described in a previous study (18,19). Melanocytes were cultivated in M2 medium (PromoCell GmbH, Heidelberg, Germany). All cell lines were incubated at 37°C in an 8% CO2 humidified atmosphere.

NHEMs were treated with the chemical mitogen-activated protein (MAP) kinase inhibitors PD98059 and UO126 [specific for MAP kinase kinase (MEK) 1 and MEK2; both Calbiochem; Merck KGaA, Darmstadt, Germany] for 6 h. Control cells were incubated with the vehicle dimethyl sulfoxide alone.

UVB radiation

UVB radiation of NHEMs seeded in M2 medium (PromoCell, Heidelberg, Germany) without PMA was performed with defined UVB doses (Whatman Biometra Transilluminator; Biometra GmbH, Göttingen, Germany). Kinase inhibitors were added before UVB radiation at a concentration of 20 µM, and due to their light sensitivity, renewed immediately after radiation in fresh medium at a concentration of 10 µM. For quenching of singlet oxygen, cells were treated with histidine (50 mM in PBS) 1 h prior to and during UVB administration (80 mJ/cm2). The irradiated cells were maintained at 37°C in a 5% CO2 atmosphere for 3 h (Mel Ei cells) and 5 h (NHEMs).

Expression analysis

Isolation of total cellular RNA from the Mel Ei, Mel Im cell lines and primary NHEM was performed using the E.Z.N.A. MicroElute Total RNA kit (Omega Bio-Tek, VWR Darmstadt, Germany) according to the manufacturer's protocol. RNA concentration was measured with a NanoDrop spectrophotometer (NanoDrop Technologies; Thermo Fisher Scientific, Inc., Wilmington, DE, USA) and cDNA was generated by reverse transcription using the Super Script II Reverse Transcriptase kit (Thermo Fisher Scientific. Inc., Waltham, MA, USA), with each reaction containing 500 ng of total RNA according to the protocol of the manufacturer. Analysis of mRNA expression was performed using quantitative Real-Time PCR on the LightCycler 480 system (Roche Diagnostics GmbH, Mannheim, Germany). A volume of 1 µl cDNA template, 0.5 µl of forward and reverse primers (each 20 µM) and 10 µl of SYBR Green I (Roche Diagnostics GmbH) were combined to a total volume of 20 µl. Specific primers for CYLD, cyclin D1, N-cadherin and SNAIL1 expression analysis are summarized in Table I. The housekeeping gene was β-actin (Table I).

Table I.

Primer sequences for expression analysis of cyclin D1, CYLD, N-cadherin, SNAIL and β-actin.

Table I.

Primer sequences for expression analysis of cyclin D1, CYLD, N-cadherin, SNAIL and β-actin.

GenePrimer sequence

[i] CYLD, CYLD lysine 63 deubiquitinase; N-cadherin, Neural cadherin; SNAIL, snail family transcriptional repressor 1; F, forward; R, reverse.

Protein analysis

Protein extraction, analysis and western blotting were performed as previously described (20), applying the following primary antibodies: Polyclonal anti-CYLD [cat. no. 4495; dilution, 1:1,000; Cell Signaling Technology, Inc., Danvers, MA, USA; (21)], anti-p44/42 MAP kinase (cat. no. 9102; dilution, 1:1,000) or anti-phospho-p44/42 MAP kinase (cat. no. 4370; dilution, 1:1,000; both Cell Signaling Technology, Inc.) and anti- β-actin (cat. no. A5441; dilution, 1:5,000; Sigma-Aldrich; Merck KGaA).

Transfection/transduction of cell lines

To express p65 and an adenoviral negative form of IκB (AdVdnIκB) (22), melanoma cells were transiently transfected or transduced with the expression plasmid or adenovirus, respectively as previously described (23).

Statistical analysis

All experiments were performed on at least 3 independent occasions. Results are presented as the mean ± standard error of the mean (SEM). Comparison between groups was made using a one-way analysis of variance followed by a Kruskal-Wallis test, and comparisons between CYLD expression in NHEM cells with and without UVB exposure were calculated by unpaired Student's t-test. All calculations were performed using the GraphPad Prism 7 software (GraphPad Software Inc., San Diego, CA, USA).


ERK and SNAIL regulation by UVB irradiation in melanocytes

As the processes of proliferation and migration in melanocytes have a physiological as well as pathophysiological role, the present study determined whether there is an association between UVB radiation exposure and expression of ERK and SNAIL1 in melanocytes. It was identified that UVB-radiation induced SNAIL1 mRNA expression in a dose-dependent manner in NHEMs; the most effective dose was 80 mJ/cm2 (Fig. 1A). This induction was also observed in the primary melanoma Mel Ei cells using the most effective UVB dose of 80 mJ/cm2 (Fig. 1B). In the present study, it was further revealed that the maximum SNAIL1 mRNA level was reached after 180 min of UVB radiation, demonstrating a fast regulation of transcription.

To determine the mechanism of this UVB mediated SNAIL expression, ERK signaling was first concentrated on. Dose-dependent ERK activation by UV radiation in melanocytes was identified (Fig. 1C). Pretreatment of NHEMs with ERK-inhibitors (UO126 or PD98059) (Fig. 1D) significantly inhibited UVB induction of SNAIL1 expression, although the base level was not completely reached.

To determine the role of UV-induced reactive oxygen species (ROS), NHEMs were pretreated with histidine (quencher to inhibit the formation of free radicals) prior to UV irradiation. Notably, histidine treatment almost completely inhibited UVB effects on SNAIL1 expression (Fig. 1E). This indicates that UVB can induce SNAIL1 expression in NHEMs via free radical-mediated ERK activation.

CYLD regulation by UVB irradiation in melanocytes

Since SNAIL1 inhibited CYLD expression in melanoma cells (16), it was investigated whether the UVB-induced increase in SNAIL1 also affects CYLD levels in NHEMs or whether this is a cancer-specific regulation. Notably, UVB-radiation also led to the downregulation of CYLD mRNA (Fig. 2A) and protein (Fig. 2B) levels in NHEMs. Treatment with histidine (Fig. 2B and C) as well as with ERK-inhibitors (Fig. 2D) inhibited the UVB-induced downregulation of CYLD. These data indicate that UVB-induces ERK activation, and as a consequence, SNAIL1 expression led to the downregulation of CYLD in non-tumorous melanocytes similar, to the regulation found in malignant melanoma cells.

NF-κB involvement in the UVB dependent signaling cascade in melanocytes

As previous studies have suggested that SNAIL1 is a possible downstream target of NF-κB (24), the present study further explored the role of this signaling pathway on SNAIL1 and CYLD expression in NHEMs and melanoma cells. Adenoviral transduction of a dominant negative form of IκB (AdVdnIκB) (25) into Mel Im melanoma cells was performed, and the Mel Im cells were transiently transfected with a p65 (NF-κB subunit) expression plasmid. Neither SNAIL1 nor CYLD mRNA expression were significantly affected by p65 overexpression or AdVdnIκB (Fig. 3A and B). Expression of a dominant-negative form of IκB also failed to inhibit UVB-induced SNAIL1 expression in NHEMs (Fig. 3C). Furthermore, inhibition of the NF-κB pathway did not significantly affect UV-mediated CYLD expression in NHEMs (Fig. 3D). Based on these data, it was concluded that UV-dependent downregulation of CYLD expression in NHEMs is not mediated by the NF-κB pathway, but rather by the ROS/ERK/SNAIL1 axis.


UV-radiation is as an initiating factor in nevus formation. On the basis of the anatomical distribution of acquired nevi and a UV-associated mutation signature in the majority of the somatic mutations of nevi, it is hypothesized that UV radiation also contributes to melanoma initiation (4,9).

When pigment cells undergo neoplastic transformation, these pathological derivatives are usually termed according to the pigment that characterized the original cell lineage, such as melanoma cells from melanocytes. Melanoma can arise spontaneously in a variety of animals, including dogs, horses, pigs and several fish. However, melanoma can also be induced by exposure to UV irradiation and carcinogens, or by the presence of relevant genetic changes in melanocytes (26). In previous years, varieties of genetic changes have been characterized in human melanocytic neoplasms and often correlate strongly with specific morphological characteristics (4). While progress has been made on defining the genetic changes present in melanoma, much remains to be learned about the specific characteristics of early malignant transformation of the melanocytes. As an example, approximately one-half of all melanomas in humans harbor oncogenic mutations in the BRAF gene (e.g., V600E), which leads to constitutive activation of the RAS-RAF-MEK-ERK (p44/p42; MAPK) signaling pathway (4,27). In contrast to melanoma cells, melanocytes exhibit low ERK-activity and the question of which early processes provoke pathological processes in melanocytes remains.

Epidemiological studies indicate the importance of UV radiation in the etiology of melanoma, and since UV-associated mutations are relatively rare in melanoma, it was speculated that UV radiation may support melanoma development by indirect effects (28,29). As a physiological response, melanocytes migrate to skin areas exposed to solar radiation, and start to proliferate and produce melanin, thereby exhibiting their protective effect against UV radiation (30). The signaling molecules involved in the stimulation of migration and proliferation of melanocytes following UV exposure remain unclear. However, the present study demonstrated that UVB radiation induces ERK-activity in melanocytes (NHEMs), similarly as previously shown in keratinocytes and melanoma cells (31,32). Additionally, UVB radiation triggered ERK-mediated SNAIL1 induction and downregulation of CYLD expression in NHEMs. Following malignant transformation, constitutive high ERK activity and SNAIL1 expression allow melanoma cells permanently to exploit this mechanism to obtain a more aggressive phenotype (16,17,23).

Previously, UVB light was identified as a trigger for direct association of CYLD with B-cell lymphoma-3 (BCL-3) (21). Following this association, CYLD removes lysine 63-linked polyubiquitin chains from BCL-3, which in turn prevents BCL-3 from translocating into the nucleus and further expressing different genes in keratinocytes (21). It was observed in malignant melanoma that loss of CYLD also induces nuclear accumulation of BCL-3 and NF-κB activation, with the consequence of induced N-cadherin (migration) and cyclin D1 (proliferation) activity (16). Data from embryogenesis and studies in Drosophila (24,3335), suggesting that SNAIL1 is regulated by Dorsal (NF-κB), were reassessed in the present study. However, it was found that in melanoma ERK signaling appears to be the major pathway responsible for the high constitutive activation of SNAIL1. While the migration and proliferation of melanocytes in response to UV are physiological with regards to skin protection by melanin, long-lasting UV radiation, which is considered as one of the main risk factors for the development of melanoma, may shift these cells towards malignant transformation. In normal epidermal melanocytes, UVB radiation induces ERK-activation and subsequently upregulates SNAIL1 expression. The repression of CYLD by SNAIL1 allows degeneration of melanocytes.

In melanoma cells, constitutively high ERK-activity (potentially caused by B-RAF mutations) leads to high SNAIL1 expression, which in turn causes a high and strong suppression of CYLD. Activation of cyclinD1 and N-cadherin leads to an increased proliferation rate of melanoma cells and contributes to the progression and metastasis of tumors.


The authors would like to thank the technicians Mrs. Lisa Ellmann (University Hospital, Regensburg, Germany) and Mrs. Nadja Schneider (Friedrich-Alexander University, Erlangen, Germany) for technical assistance. This study was supported by grants from the German Research Foundation to S.K., C.H. and A.B. within the research consortium (grant no. FOR2172).





ultraviolet B


snail family transcriptional repressor 1


normal human epidermal melanocytes


extracellular signal-regulated kinase



Rowe CJ and Khosrotehrani K: Clinical and biological determinants of melanoma progression: Should all be considered for clinical management? Australas J Dermatol. 57:175–181. 2016. View Article : Google Scholar : PubMed/NCBI


Qadir MI: Skin cancer: Etiology and management. Pak J Pharm Sci. 29:999–1003. 2016.PubMed/NCBI


Cui R, Widlund HR, Feige E, Lin JY, Wilensky DL, Igras VE, D'Orazio J, Fung CY, Schanbacher CF, Granter SR and Fisher DE: Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell. 128:853–864. 2007. View Article : Google Scholar : PubMed/NCBI


Bastian BC: The molecular pathology of melanoma: An integrated taxonomy of melanocytic neoplasia. Annu Rev Pathol. 9:239–271. 2014. View Article : Google Scholar : PubMed/NCBI


Premi S, Wallisch S, Mano CM, Weiner AB, Bacchiocchi A, Wakamatsu K, Bechara EJ, Halaban R, Douki T and Brash DE: Photochemistry. Chemiexcitation of melanin derivatives induces DNA photoproducts long after UV exposure. Science. 347:842–847. 2015. View Article : Google Scholar : PubMed/NCBI


Nishisgori C: Current concept of photocarcinogenesis. Photochem Photobiol Sci. 14:1713–1721. 2015. View Article : Google Scholar : PubMed/NCBI


de Gruijl FR: Photocarcinogenesis: UVA vs UVB. Methods Enzymol. 319:359–366. 2000. View Article : Google Scholar : PubMed/NCBI


Tornaletti S and Pfeifer GP: UV damage and repair mechanisms in mammalian cells. Bioessays. 18:221–228. 1996. View Article : Google Scholar : PubMed/NCBI


Seebode C, Lehmann J and Emmert S: Photocarcinogenesis and Skin Cancer Prevention Strategies. Anticancer Res. 36:1371–1378. 2016.PubMed/NCBI


De Fabo EC, Noonan FP, Fears T and Merlino G: Ultraviolet B but not ultraviolet A radiation initiates melanoma. Cancer Res. 64:6372–6376. 2004. View Article : Google Scholar : PubMed/NCBI


Noonan FP, Recio JA, Takayama H, Duray P, Anver MR, Rush WL, De Fabo EC and Merlino G: Neonatal sunburn and melanoma in mice. Nature. 413:271–272. 2001. View Article : Google Scholar : PubMed/NCBI


Halliday GM, Agar NS, Barnetson RS, Ananthaswamy HN and Jones AM: UV-A fingerprint mutations in human skin cancer. Photochem Photobiol. 81:3–8. 2005. View Article : Google Scholar : PubMed/NCBI


Gandini S, Sera F, Cattaruzza MS, Pasquini P, Picconi O, Boyle P and Melchi CF: Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer. 41:45–60. 2005. View Article : Google Scholar : PubMed/NCBI


Bignell GR, Warren W, Seal S, Takahashi M, Rapley E, Barfoot R, Green H, Brown C, Biggs PJ, Lakhani SR, et al: Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet. 25:160–165. 2000. View Article : Google Scholar : PubMed/NCBI


Kuphal S, Shaw-Hallgren G, Eberl M, Karrer S, Aberger F, Bosserhoff AK and Massoumi R: GLI1-dependent transcriptional repression of CYLD in basal cell carcinoma. Oncogene. 30:4523–4530. 2011. View Article : Google Scholar : PubMed/NCBI


Massoumi R, Kuphal S, Hellerbrand C, Haas B, Wild P, Spruss T, Pfeifer A, Fässler R and Bosserhoff AK: Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma. J Exp Med. 206:221–232. 2009. View Article : Google Scholar : PubMed/NCBI


Kuphal S, Palm HG, Poser I and Bosserhoff AK: Snail-regulated genes in malignant melanoma. Melanoma Res. 15:305–313. 2005. View Article : Google Scholar : PubMed/NCBI


Ziegler-Heitbrock HW, Munker R, Johnson J, Petersmann I, Schmoeckel C and Riethmuller G: In vitro differentiation of human melanoma cells analyzed with monoclonal antibodies. Cancer Res. 45:1344–1350. 1985.PubMed/NCBI


Tsuji T and Karasek M: A procedure for the isolation of primary cultures of melanocytes from newborn and adult human skin. J Invest Dermatol. 81:179–180. 1983. View Article : Google Scholar : PubMed/NCBI


Spangler B, Kappelmann M, Schittek B, Meierjohann S, Vardimon L, Bosserhoff AK and Kuphal S: ETS-1/RhoC signaling regulates the transcription factor c-Jun in melanoma. Int J Cancer. 130:2801–2811. 2012. View Article : Google Scholar : PubMed/NCBI


Massoumi R, Chmielarska K, Hennecke K, Pfeifer A and Fässler R: Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling. Cell. 125:665–677. 2006. View Article : Google Scholar : PubMed/NCBI


Jobin C, Hellerbrand C, Licato LL, Brenner DA and Sartor RB: Mediation by NF-kappa B of cytokine induced expression of intercellular adhesion molecule 1 (ICAM-1) in an intestinal epithelial cell line, a process blocked by proteasome inhibitors. Gut. 42:779–787. 1998. View Article : Google Scholar : PubMed/NCBI


Kuphal S, Poser I, Jobin C, Hellerbrand C and Bosserhoff AK: Loss of E-cadherin leads to upregulation of NFkappaB activity in malignant melanoma. Oncogene. 23:8509–8519. 2004. View Article : Google Scholar : PubMed/NCBI


Barberà MJ, Puig I, Domínguez D, Julien-Grille S, Guaita-Esteruelas S, Peiró S, Baulida J, Francí C, Dedhar S, Larue L, et al: Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells. Oncogene. 23:7345–7354. 2004. View Article : Google Scholar : PubMed/NCBI


Hellerbrand C, Jobin C, Iimuro Y, Licato L, Sartor RB and Brenner DA: Inhibition of NFkappaB in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor. Hepatology. 27:1285–1295. 1998. View Article : Google Scholar : PubMed/NCBI


Schartl M, Larue L, Goda M, Bosenberg MW, Hashimoto H and Kelsh RN: What is a vertebrate pigment cell? Pigment Cell Melanoma Res. 29:8–14. 2016. View Article : Google Scholar : PubMed/NCBI


Guadarrama-Orozco JA, Ortega-Gómez A, Ruiz-García EB, Astudillo-de la Vega H, Meneses-García A and Lopez-Camarillo C: Braf V600E mutation in melanoma: Translational current scenario. Clin Transl Oncol. 18:863–871. 2016. View Article : Google Scholar : PubMed/NCBI


Brenner M, Degitz K, Besch R and Berking C: Differential expression of melanoma-associated growth factors in keratinocytes and fibroblasts by ultraviolet A and ultraviolet B radiation. Br J Dermatol. 153:733–739. 2005. View Article : Google Scholar : PubMed/NCBI


Jhappan C, Noonan FP and Merlino G: Ultraviolet radiation and cutaneous malignant melanoma. Oncogene. 22:3099–3112. 2003. View Article : Google Scholar : PubMed/NCBI


Esparza-Soto M, Fox P and Westerhoff P: Transformation of molecular weight distributions of dissolved organic carbon and UV-absorbing compounds at full-scale wastewater-treatment plants. Water Environ Res. 78:253–262. 2006. View Article : Google Scholar : PubMed/NCBI


Pak BJ, Lee J, Thai BL, Fuchs SY, Shaked Y, Ronai Z, Kerbel RS and Ben-David Y: Radiation resistance of human melanoma analysed by retroviral insertional mutagenesis reveals a possible role for dopachrome tautomerase. Oncogene. 23:30–38. 2004. View Article : Google Scholar : PubMed/NCBI


Peus D, Meves A, Vasa RA, Beyerle A, O'Brien T and Pittelkow MR: H2O2 is required for UVB-induced EGF receptor and downstream signaling pathway activation. Free Radic Biol Med. 27:1197–1202. 1999. View Article : Google Scholar : PubMed/NCBI


Ip YT: Transcriptional regulation. Converting an activator into a repressor. Curr Biol. 5:1–3. 1995. View Article : Google Scholar : PubMed/NCBI


Ip YT, Park RE, Kosman D, Yazdanbakhsh K and Levine M: dorsal-twist interactions establish snail expression in the presumptive mesoderm of the Drosophila embryo. Genes Dev. 6:1518–1530. 1992. View Article : Google Scholar : PubMed/NCBI


Marchal L, Foucaul A, Patissier G, Rosant JM and Legrand J: Influence of flow patterns on chromatographic efficiency in centrifugal partition chromatography. J Chromatogr A. 869:339–352. 2000. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

Volume 14 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
Spandidos Publications style
Kuphal S, Schneider N, Massoumi R, Hellerbrand C and Bosserhoff AK: UVB radiation represses CYLD expression in melanocytes. Oncol Lett 14: 7262-7268, 2017
Kuphal, S., Schneider, N., Massoumi, R., Hellerbrand, C., & Bosserhoff, A.K. (2017). UVB radiation represses CYLD expression in melanocytes. Oncology Letters, 14, 7262-7268.
Kuphal, S., Schneider, N., Massoumi, R., Hellerbrand, C., Bosserhoff, A. K."UVB radiation represses CYLD expression in melanocytes". Oncology Letters 14.6 (2017): 7262-7268.
Kuphal, S., Schneider, N., Massoumi, R., Hellerbrand, C., Bosserhoff, A. K."UVB radiation represses CYLD expression in melanocytes". Oncology Letters 14, no. 6 (2017): 7262-7268.